- $2.12bn
- $1.94bn
- $176.03m
Annual balance sheet for HeartFlow, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 123 | 51.4 | 177 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 20.5 | 24.6 | 29.3 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 148 | 82.3 | 220 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 30.9 | 27.7 | 26.1 |
| Long Term Investments | |||
| Other Long Term Assets | |||
| Total Assets | 185 | 119 | 359 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Current Liabilities | 32.8 | 33.6 | 42.4 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 194 | 210 | 58.8 |
| Redeemable Preferred Stock | |||
| Non Redeemable Preferred Stock | |||
| Common Stock | |||
| Additional Paid In Capital | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | -9 | -90.9 | 301 |
| Total Liabilities & Shareholders' Equity | 185 | 119 | 359 |
| Total Common Shares Outstanding |